Status:
COMPLETED
Bone Marrow Cells With Core Decompression for AVN Treatment
Lead Sponsor:
Global Stem Cell Center, Baghdad
Conditions:
Avascular Necrosis of the Femoral Head
Eligibility:
All Genders
25-55 years
Phase:
NA
Brief Summary
Avascular necrosis of the femoral head (AVN) is a progressive pathological process resulting from disruption of blood supply to the femoral head and elevation of intraosseous pressure. total hip arthr...
Detailed Description
Avascular necrosis of the femoral head (AVN) is a progressive pathological process resulting from disruption of blood supply to the femoral head and elevation of intraosseous pressure. Early stage AVN...
Eligibility Criteria
Inclusion
- Avascular hip necrosis irrespective Of stage.
- age from 25-55 years. -
Exclusion
- history of bleeding tendency.
- history of malignant disease.
- critically ill patient. -
Key Trial Info
Start Date :
August 10 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 28 2024
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT05982054
Start Date
August 10 2023
End Date
July 28 2024
Last Update
July 30 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ministry of Health
Baghdad, Iraq, 964